Akari Therapeutics Plc ADR

AKTXNASDAQ · USD
9.81USD0.00 (+0.57%)
212

Akari Therapeutics Plc ADR (AKTX) Option Chain

As of September 25, 2026, Akari Therapeutics Plc ADR is trading at $9.81, a +0.57% change from the previous close. The nearest expiration is Oct 16, 2026. Implied volatility is 207.9%. IV Rank is —%.

Read more

Tracking the AKTX option chain helps you see every strike and expiry on Akari Therapeutics Plc ADR in one view, so you can quickly identify the contracts that fit your thesis and your risk. Akari Therapeutics Plc ADR's option chain lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of AKTX options activity at a glance. Use our scanner to monitor the AKTX option chain in real time and filter for the AKTX options trades that actually meet your criteria.

An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For AKTX stock options, the chain shows side-by-side call and put data, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading the AKTX option chain effectively means looking beyond the last price — implied volatility by strike, volume-to-open-interest ratios, and bid-ask spreads all tell you where AKTX stock options are being actively traded and where they are not.

Akari Therapeutics, Plc is a clinical-stage biotechnology firm dedicated to advancing novel treatments for autoimmune and inflammatory disorders. The company's primary investigational therapy is nomacopan, an advanced, second-generation complement inhibitor. This drug is engineered to counteract both inflammatory and prothrombotic processes. Nomacopan holds promise for a range of serious conditions, including paroxysmal nocturnal hemoglobinuria (PNH), Guillain-Barré syndrome (GBS), hematopoietic stem cell transplant-associated thrombotic microangiopathy (HSCT-TMA), and bullous pemphigoid (BP). Akari's operations are headquartered in London, United Kingdom.

Credit spreads, long calls, iron condors, calendar trades — every strategy starts with the same raw material: a clean, complete option chain. Our scanner pulls Akari Therapeutics Plc ADR's full chain across every expiry, highlights the most liquid strikes, and lets you screen AKTX options by the metrics that matter, from IV skew to volume surges. Stop scrolling through endless rows of AKTX stock options — let the full option chain come to you, pre-filtered and ready to trade.

Stock Statistics

  • IndustryBiotechnology
  • SectorHealthcare
  • IV percentile—
  • Market cap (M$)17
  • 52 weeks high-77.91%
  • 52 weeks low224.83%
  • Analyst recommendationStrong Buy
    1.00
  • Target price$25.50
    159.94% above the current stock price
  • Dividend—
  • Payout ratio—
  • Earnings date2026-12-04
  • P/E—
  • Future P/E—
  • EPS (ttm)-17.25
  • EPS growth next 5 years46.65%

As of September 25, 2026

2026-10-16
5 strikes
Default
CALLsPUTs
Prob. OTM %Open InterestVolumeExtrinsic ValueIntrinsic ValueBidAskStrikeMoneyness %BidAskIntrinsic ValueExtrinsic ValueVolumeOpen InterestProb. OTM %
10.0000-0.014.813.206.405.00-48.77—1.500.001.500090.00
35.48000.642.311.504.407.50-23.16—2.050.002.050064.52
60.73001.650.000.203.1010.00+2.460.453.300.191.690039.27
78.01002.900.00—2.9012.50+28.072.355.102.691.040021.99
88.12002.450.00—2.4515.00+53.694.507.405.190.760011.88

As of September 25, 2026

Scan the full option chain in one place

Browse the full AKTX option chain across every strike and expiration, filter by IV, volume, and open interest, and evaluate your trade without switching tools.

Start your 14-day free trial